3.0
Dec 19, 2013
Former employee, more than 3 years
Kyiv, Kyiv
Recommend
CEO approval
Business Outlook
Pros
Big multinational with strong corporate culture. Good focus on training employees. Average to high salary level, depending on the county. Advanced bonus system.
Cons
Since change of CEO in 2012 the company had massive job cuts and restructuring. Second main office in Brussels was closed with 60% employees leaving. Many local markets changed the top management. After expiration of crestor patent, and failure to introduce new molecules, company is in tough financial situation.